Other languages Alaunos Therapeutics, Inc.

Equities

TCRT

US98973P2002

Market Closed - Nasdaq Other stock markets 02:00:00 07/05/2024 am IST			5-day change	1st Jan Change
1.32 ^USD	+1.54%		-0.75%	+24.47%

01/04	Alaunos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
05/03	North American Morning Briefing : S&P 500 Futures -2-	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alaunos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Alaunos Therapeutics, Inc. Appoints Dale Curtis Hogue, Jr. as Interim Chief Executive Officer	23/01
Alaunos Therapeutics, Inc. Appoints Dale Curtis Hogue as Director	02/01
Alaunos Therapeutics, Inc. Announces the Resignation of Mary Thistle as Member of the Board of Directors	22/12
Alaunos Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Alaunos Therapeutics, Inc. Announces Board Changes	29/23/29
Sector Update: Health Care Stocks Slip Pre-Bell Tuesday	15/23/15
Alaunos Therapeutics to Cut Staff by 60%; Considering Strategic Alternatives; Shares Plummet Pre-Bell	15/23/15
Alaunos Therapeutics Announces Exploration of Strategic Alternatives	15/23/15
Alaunos Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2023	15/23/15
Alaunos Therapeutics Announces Presentation At the 2Nd Hawaii Global Summit on Thoracic Malignancies	29/23/29
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting	26/23/26
Alaunos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10
Precigen, Inc. Announces Amendment of Its Exclusive License Agreement with Alaunos Therapeutics, Inc	04/23/04
Alaunos Therapeutics, Inc. Announces Resignation of Christopher Bowden as Board of Directors	30/23/30
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors	30/23/30
Alaunos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	07/23/07
Alaunos Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	07/23/07
Alaunos Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	07/23/07
Alaunos Therapeutics Expects $15.7 Million in Gross Proceeds From Common Shares Offering	29/22/29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Alaunos Therapeutics, Inc.

Equities

TCRT

US98973P2002

Other languages

Filters